Drug Profile


Alternative Names: Cereport; Lobradimil; Receptor-mediated permeabiliser 7; RMP-7

Latest Information Update: 30 Sep 2014

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Alkermes
  • Developer Alkermes; ALZA Corporation
  • Class Adjuvants; Kinins; Neuropeptides; Oligopeptides
  • Mechanism of Action Bradykinin B2 receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Brain cancer; Cancer metastases; Cryptococcosis; Glioma; HIV infections

Most Recent Events

  • 30 Sep 2014 Discontinued - Phase-I for Cryptococcosis (Cryptococcal meningitis) in USA (IV)
  • 30 Sep 2014 Discontinued - Phase-I for HIV infections (Cryptococcal meningitis) in USA (IV)
  • 30 Sep 2014 Discontinued - Phase-II for Brain cancer in USA (Intra-arterial)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top